Tag: National Home Infusion Association (NHIA)
In brief: Reimbursement relief, MA guardrails, Numotion pilot
December 6, 2024HME News Staff
WASHINGTON – More than 30 leading patient advocacy organizations have weighed in with congressional leadership to support including provisions from H.R. 5555 and S. 1294 in any legislative package that moves before the end of the year, AAHomecare reports.
In a Dec. 2 letter from the ITEM Coalition, the groups assert that the expiration of 75/25 blended Medicare reimbursement rates on Jan. 1, 2024, has resulted in a “crushing blow to DMEPOS suppliers and providers, threatening...
Analysis: NHIA’s changes could save billion-plus
December 5, 2024HME News Staff
WASHINGTON – An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives and to bundle payments for disposable supplies with the services payment would generate significant savings for Medicare. On the IV anti-infective policy, Magnolia provides two savings estimates based on the magnitude of patients that would migrate from...
NHIA welcomes Melinta Therapeutics to advisory council
December 2, 2024HME News Staff
ALEXANDRIA, Va., and PARSIPPANY, N.J. – The National Home Infusion Association has announced that Melinta Therapeutics, a commercial-stage company providing therapies for acute and life-threatening illnesses, has joined its Future of Infusion Advisory Council (FIAC). The strategic advisory group, which is comprised of manufacturing and service companies invested in the home and alternate site infusion industry, works with association staff and the board of directors to address critical issues,...
Infusion stakeholders send new letter
November 13, 2024HME News Staff
ALEXANDRIA, Va. — A group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services.
In a letter to lawmakers, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104), which would include pharmacy services as part of the home infusion therapy benefit under Medicare and cover everything from assessments to drug preparation and compounding...
Recent IV shortages call for real fix, stakeholders say
November 8, 2024Theresa Flaherty, Managing Editor
YARMOUTH, Maine – A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy solutions, says Connie Sullivan of the National Home Infusion Association.
While flooding in September halted production of intravenous solution bags at the Baxter International plant in Marion, N.C., chronic shortages of IV solutions, enteral formulas and other products are an ongoing concern, she says.
“This patient community has...
NHIA urges more steps in addressing IV solution shortage
October 16, 2024HME News Staff
WASHINGTON – The National Home Infusion Association believes more needs to be done to minimize the impact on patient care and ensure equitable access to life-savings IV therapies after flooding halted production at the Baxter International plant in Marion, N.C. In a letter to Department of Health and Human Services Secretary Xavier Becerra, the association wrote: “As the leading voice for the home and alternate site infusion community, we write to share our concerns and offer recommendations...
NHIA develops drug list
August 13, 2024HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association has developed a list of medications to serve as a reference when making site of care decisions for patients requiring intravenous or subcutaneous infusions. The list reflects current U.S. prescribing practices and was compiled from medication dispensing reports from home infusion providers and reviewed by NHIA’s Quality and Standards Committee. “Home infusion providers have special expertise in the assessment, coordination...
NHIA wraps successful event
April 3, 2024HME News Staff
ALEXANDRIA, Va. — The 2024 National Home Infusion Association Annual Conference drew more than 1,600 home and alternate site infusion professionals for four days of networking, education and exhibits. This year's event saw significant growth in attendance and exhibits over prior years and the expo featured more than 135 companies displaying the latest products and services supporting the industry, according to NHIA. In addition to previously announced awards, NHIA recognized infusion patient...
NHIA names groundbreaking products
March 25, 2024HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award: Avoset from Eitan Medical, Brightree Pharmacy Outcomes from Brightree, Eitan Insights from Eitan Medical and the Orchid Safety Release Valve from Linear Health Sciences. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry. “I would like to thank all of the companies who participated as well as all...
Part B infusion visits decrease
March 20, 2024HME News Staff
WASHINGTON – Home infusion service visits continued to decline in the first half of 2023, according to CMS’s annual monitoring report on the Medicare Part B home infusion therapy (HIT) benefit. The HIT market is concentrated, with seven of the 82 HIT suppliers providing about 56% of the HIT service visits in the past 12 months. The quarterly number of HIT supplier organizations increased from 42 in Q1 2021 to a quarterly high of 74 in Q3 2022 before dropping to 60 in Q2 2023, according...